Top US Biomedical Researcher Praised Prof. Mike Chan’s State-of-the-Art European Wellness Premier Center at Kota Kinabalu

KOTA KINABALU, Malaysia (Nov 8, 2024) – Veteran biomedical researcher and CEO Robert Settineri lauded the European Wellness Premier Center as an “absolute sanctuary” during his recent visit, bringing over three decades of pharmaceutical expertise to bear in his assessment of the facility’s bio-regenerative treatments.

Settineri, who heads Sierra Production Research and holds four medical patents, expressed particular admiration for Professor Mike Chan’s pioneering work. “Having attended Professor Chan’s conferences six times and studied his publications extensively, I can attest that his approach to regenerative medicine is truly groundbreaking,” said Settineri, whose own research has been published in more than 50 scientific articles.

The scientist’s enthusiasm stems from his personal experience at the center, where he underwent successful stem cell treatment for shoulder pain. “The relief was remarkable,” said Settineri, whose background includes managing FDA applications across 80 countries. “The level of care here exemplifies why I’ve followed Professor Chan’s work so closely over the years.”

A seasoned medical educator himself, Settineri has produced award-winning educational videos, including “Immuno-Imagery,” which has been translated into six languages and received 37 international awards. His book “Detox Outside the Box” has reached thousands of healthcare professionals, reflecting his commitment to advancing medical knowledge.

During his visit, Settineri participated in several therapeutic sessions, including hydrogen inhalation. As the former Senior Vice President of the American Nutraceutical Association, he emphasized how the center’s comprehensive approach to wellness aligned with his extensive research in bioregenerative medicine.

A proposed collaborative project between Settineri and Chan to create promotional materials about the center’s innovative treatments is currently under discussion. “While still in the proposal stage, we hope to showcase these groundbreaking therapies to a global audience,” Settineri explained, drawing on his experience in biomedical communications and research coordination.
The researcher plans to return to California, where he aims to organize educational initiatives about bio-regenerative medicine. “The medical community needs to understand these advanced treatment options,” said Settineri, whose work in formulating and clinically researching healthcare products has earned him multiple patents in membrane phospholipid supplements and EDTA administration.

“Professor Chan’s work here represents the pinnacle of bio-regenerative medicine,” concluded Settineri, whose career spans both pharmaceutical research and practical healthcare solutions. “I’m committed to helping spread awareness about these innovative approaches that could reshape the future of medicine.”